Industry
Biotechnology
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Loading...
Open
2.66
Mkt cap
293M
Volume
1.7M
High
2.69
P/E Ratio
-2.77
52-wk high
6.72
Low
2.52
Div yield
N/A
52-wk low
1.35
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.